Eosinophilic fasciitis induced by certolizumab pegol: association or coincidence?

Clin Exp Rheumatol. 2023 Sep;41 Suppl 135(9):17. doi: 10.55563/clinexprheumatol/am8x3p. Epub 2022 Jun 14.

Authors

Gang Wang¹, Ning Zhuo², Zhenhua Wen³

Affiliations

¹ Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
² Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
³ Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, Hunan, China. zhenhuawen2021@126.com.

PMID: 35766000
DOI: 10.55563/clinexprheumatol/am8x3p

No abstract available

Publication types

Letter
Comment

MeSH terms

Certolizumab Pegol / adverse effects
Eosinophilia* / chemically induced
Fasciitis* / chemically induced
Fasciitis* / drug therapy
Humans
Immunoglobulin Fab Fragments
Polyethylene Glycols / adverse effects

Substances

Certolizumab Pegol
Immunoglobulin Fab Fragments
Polyethylene Glycols

Supplementary concepts

Eosinophilic Fasciitis